Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody.

Tong, A W; Lee, J; Wang, R M; Dalton, W S; Tsuruo, T; Fay, J W; Stone, M J

Tong, A W; Lee, J; Wang, R M; Dalton, W S; Tsuruo, T; Fay, J W; Stone, M J.

Affiliation

Tong AW; Cancer Immunology Research Unit, Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas 75246.

Cancer Res ; 49(17): 4829-34, 1989 Sep 01.

Article in En | MEDLINE | ID: mdl-2569359

Subject(s)

Antibodies, Monoclonal/therapeutic use; Membrane Glycoproteins/immunology; Multiple Myeloma/therapy; Plasma Cells/immunology; ATP Binding Cassette Transporter, Subfamily B, Member 1; Antineoplastic Agents/pharmacology; Bone Marrow Cells; Doxorubicin/pharmacology; Drug Resistance; Humans; Multiple Myeloma/immunology; Neoplastic Stem Cells/drug effects; Neoplastic Stem Cells/immunology; Phenotype; Tumor Cells, Cultured

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Plasma Cells / Membrane Glycoproteins / Antibodies, Monoclonal / Multiple Myeloma Limits: Humans Language: En Journal: Cancer Res Year: 1989 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links